Superiority Trial
The primary objective of a superiority trial is to demonstrate that the response to the treatment being tested is superior to another treatment. Whether or not that other treatment contains active or inactive ingredients.
The primary objective of a superiority trial is to demonstrate that the response to the treatment being tested is superior to another treatment. Whether or not that other treatment contains active or inactive ingredients.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
